(3-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid, 95.0%, 100mg

Éster n-butílico del ácido acético, mínimo 99 %, para síntesis, 1 l, envase de vidrio

2-Chloro-6-hydroxybenzoic acid, 95.0%, 5g

Pyrazolo[1,5-a]pyridine-2-carboxamide, 95.0%, 1g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(m-tolyl)butanoic acid, 98%, 100mg

4-Methyl-morpholin-3-one, 95.0%, 5g

(S)-tert-butyl 2-(5-(4-chlorophenyl)-6,7-dimethyl-2-oxo-2,3-dihydro-1H-thieno[2,3-e][1,4]diazepin-3-yl)acetate, 98%, 100mg

Ethyl3-bromo-6,6-difluoro-5,7-dihydropyrazolo[5,1-b][1,3]oxazine-2-carboxylate, 98%, 5g

1-Boc-3-Vinylpyrrolidine, 95.0%, 250mg

3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid, 95.0%, 100mg

(S)-Ethyl 3-(4-aminophenyl)-2-(1,3-dioxoisoindolin-2-yl)propanoate, 95.0%, 1g

7-Fluoroquinoline-3-carbonitrile, 95%, 100mg

3,6-DIIODO-1H-INDAZOLE, 95%, 25g